The evolution of the asset-centric approach in biotech venture capital

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/c2/4b/46/c24b4666-10b4-d833-a4ad-77be49cd1422/mza_18369175361314418871.jpeg/600x600bb.jpg

Conversations in Healthcare

Clarivate

48 episodes

9 months ago

Clarivate Conversations in Healthcare is a collection of candid interviews with key leaders and experts. Veteran industry journalist Mike Ward explores business challenges and opportunities the industry currently faces, including COVID-19, clinical innovation, deal making, emerging market dynamics, data and technology, new engagement models, patient centricity and much more.

Hosted on Acast. See acast.com/privacy for more information.

Business News

News

RSS

All content for Conversations in Healthcare is the property of Clarivate and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Business News

News

https://assets.pippa.io/shows/60b1306d44938a0013db19cf/1623402094721-c5ac4c7724fc4fd7f3879046a35d2447.jpeg

The evolution of the asset-centric approach in biotech venture capital

Conversations in Healthcare

47 minutes 29 seconds

4 years ago

The evolution of the asset-centric approach in biotech venture capital

In this episode of Conversations in Healthcare, Mike Ward, Head of Thought Leadership, Life Sciences and Healthcare at Clarivate, speaks with Francesco De Rubertis, a co-founder and managing partner at Medicxi, one of the most prominent financial supporters of innovative biotech activity. Francesco provides insights into how the biotech venture capital model has evolved in the past decades to an asset-centric approach, and discusses Centessa, which recently secured $250m in funding. Learn more in the full episode.

Hosted on Acast. See acast.com/privacy for more information.